Patent · US Expired

Human RNase H1 mutants

US6855530B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignee

Isis Pharmaceuticals, Inc. · US

Inventors

Hongjiang Wu · Beijing, CN
Walter F. Lima · San Diego, US
Stanley T. Crooke · Carlsbad, US

Key dates

Filing date	Nov 14, 2001
Grant date	Feb 15, 2005
Priority date	—
Expiry date	Mar 13, 2022

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K48/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A human RNase H polypeptide and methods of use are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.